Squarepoint Ops LLC Raises Position in Teleflex Incorporated (NYSE:TFX)

Squarepoint Ops LLC lifted its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 5,276.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 68,168 shares of the medical technology company's stock after purchasing an additional 66,900 shares during the quarter. Squarepoint Ops LLC owned about 0.15% of Teleflex worth $12,133,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vontobel Holding Ltd. grew its holdings in Teleflex by 21.9% in the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company's stock valued at $248,000 after buying an additional 250 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Teleflex by 5.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company's stock worth $19,263,000 after acquiring an additional 5,322 shares during the last quarter. Lecap Asset Management Ltd. purchased a new stake in Teleflex in the fourth quarter valued at approximately $729,000. Mirae Asset Global Investments Co. Ltd. increased its position in Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company's stock worth $1,053,000 after purchasing an additional 1,527 shares during the last quarter. Finally, Boston Trust Walden Corp raised its stake in Teleflex by 3.9% during the fourth quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company's stock worth $52,435,000 after purchasing an additional 11,052 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Price Performance

TFX stock opened at $120.98 on Friday. The firm has a market cap of $5.35 billion, a P/E ratio of 24.05, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 1 year low of $119.60 and a 1 year high of $249.91. The stock has a 50-day simple moving average of $131.81 and a 200-day simple moving average of $160.68.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex's quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.21 EPS. On average, equities analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date is Tuesday, May 20th. Teleflex's payout ratio is 42.90%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Piper Sandler reissued a "neutral" rating and set a $140.00 price objective (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Morgan Stanley lowered their price target on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Wall Street Zen downgraded Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Finally, Citizens Jmp downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $164.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.